Domainex

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Design & Build

New biology centre opened by HM Lord-Lieutenant of Cambridgeshire

The new three-storey facility provides over 24,000 sqft for Domainex’s expanding biology/bioanalytical departments
Drug Delivery

Amphista Therapeutics partners with Domainex drug discovery portfolio

Domainex has experience in the field of TPD with expertise in designing, synthesising, and profiling targeted heterobifunctional protein degraders
Finance

Domainex acquires more than £1m of Waters equipment

The SQ detectors will enable Domainex to increase its capacity to analyse and purify compounds with higher molecular masses
Research & Development

Domainex opens dedicated facility at Unity Campus

“The investment into our new facility has allowed us to create a fully dedicated suite of labs to conduct our biology services”
Drug Delivery

Parkinson’s UK and Domainex collaborate on inflammation therapy

The organisations plan to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s
Research & Development

Queen’s University Belfast enters FLIP inhibitor collaboration

The university will work with Ipsen on the inhibitors, which have been supported by Domainex
Research & Development

Expanding the medicinal chemist’s toolbox

Ray Boffey, Executive Director of Medicines Research at Domainex, explains the applications and benefits of fragment-based drug discovery, fragment hit expansion and the use of flow chemistry
Subscribe now